CAM
Cormorant Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Sell |
300,000
-100,000
| -25% | -$4.05M | 0.91% | 24 |
|
|
2025
Q1 | $20.5M | Sell |
400,000
-100,000
| -20% | -$5.14M | 1.55% | 19 |
|
|
2024
Q4 | $27.7M | Hold |
500,000
| – | – | 1.52% | 20 |
|
|
2024
Q3 | $16.4M | Hold |
500,000
| – | – | 0.87% | 33 |
|
|
2024
Q2 | $13.6M | Sell |
500,000
-1,639,102
| -77% | -$44.6M | 0.79% | 33 |
|
|
2024
Q1 | $77.8M | Sell |
2,139,102
-82,320
| -4% | -$2.99M | 3.41% | 8 |
|
|
2023
Q4 | $45M | Sell |
2,221,422
-400,000
| -15% | -$8.1M | 2.15% | 12 |
|
|
2023
Q3 | $46.6M | Buy |
2,621,422
+1,200,000
| +84% | +$21.3M | 2.72% | 11 |
|
|
2023
Q2 | $25.7M | Hold |
1,421,422
| – | – | 1.44% | 20 |
|
|
2023
Q1 | $17.9M | Sell |
1,421,422
-315,000
| -18% | -$3.96M | 1.18% | 23 |
|
|
2022
Q4 | $25.5M | Sell |
1,736,422
-235,000
| -12% | -$3.45M | 1.7% | 19 |
|
|
2022
Q3 | $33.8M | Buy |
1,971,422
+96,422
| +5% | +$1.65M | 2.36% | 12 |
|
|
2022
Q2 | $27.4M | Buy |
1,875,000
+499,018
| +36% | +$7.29M | 2.07% | 15 |
|
|
2022
Q1 | $23.1M | Sell |
1,375,982
-27,349
| -2% | -$460K | 1.78% | 15 |
|
|
2021
Q4 | $31.6M | Sell |
1,403,331
-41,500
| -3% | -$934K | 1.88% | 16 |
|
|
2021
Q3 | $31.1M | Sell |
1,444,831
-69,438
| -5% | -$1.5M | 1.27% | 24 |
|
|
2021
Q2 | $43.9M | Sell |
1,514,269
-200,000
| -12% | -$5.8M | 1.49% | 19 |
|
|
2021
Q1 | $55.3M | Hold |
1,714,269
| – | – | 1.23% | 17 |
|
|
2020
Q4 | $70M | Buy |
+1,714,269
| New | +$70M | 1.67% | 18 |
|